Here's the main clause: You can do whatever you like with that $30,000 and, as long as you don't blow it on the slots or take a risk on a couple of stocks, you'll probably be OK. That sweeping ...

When back-tested to 1871, this forecasting tool has an immaculate track record of projecting where stocks will head next.

Recognify Life Sciences, a company Atai Life Sciences is a strategic investor in, said its trial for a cognitive decline treatment missed its primary endpoint. Atai shares fell 13% to $3.08 in ...

The SPDR Select Sector Utilities exchange-traded fund, which tracks the rate-sensitive utilities industry group of the S&P 500, rose 0.26% for the session and is up about 5% for the month, amid hopes ...

Find insight on EFG International, Deutsche Bank and more in the latest Market Talks covering Financial Services.

Investors are benefiting as the FTSE 100 hits record highs - here are the best performing shares and funds so far this year ...

Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

DIAX writes options on a portfolio of constituents of the Dow Jones index and makes it possible to collect a higher yield than average. See why the Fund is a Buy.

Northrop Grumman is positioned to capitalize on international demand, in the Middle East and Europe, fueled by regional ...

Find insight on GM, Stellantis and more in the latest Market Talks covering Auto and Transport.

Verizon's post-earnings gain made it the best Dow Jones stock today. All in all, the blue chip Dow Jones Industrial Average ...

Stock futures were little changed on Monday night after the S&P 500 and Nasdaq Composite hit fresh records. Futures tied to ...